AAAAAA

   
Results: 1-8 |
Results: 8
EFFECTS OF REVERSE-TRANSCRIPTASE INHIBITOR THERAPY ON THE HIV-1 VIRALBURDEN IN SEMEN
Authors: GILLIAM BL DYER JR FISCUS SA MARCUS C ZHOU S WATHEN L FREIMUTH WW COHEN MS ERON JJ
Citation: Bl. Gilliam et al., EFFECTS OF REVERSE-TRANSCRIPTASE INHIBITOR THERAPY ON THE HIV-1 VIRALBURDEN IN SEMEN, Journal of acquired immune deficiency syndromes and human retrovirology, 15(1), 1997, pp. 54-60
PHARMACOKINETIC STUDY OF THE INTERACTION BETWEEN RIFABUTIN AND DELAVIRDINE MESYLATE IN HIV-1-INFECTED PATIENTS
Authors: BORIN MT CHAMBERS JH CAREL BJ FREIMUTH WW AKSENTIJEVICH S PIERGIES AA
Citation: Mt. Borin et al., PHARMACOKINETIC STUDY OF THE INTERACTION BETWEEN RIFABUTIN AND DELAVIRDINE MESYLATE IN HIV-1-INFECTED PATIENTS, Antiviral research, 35(1), 1997, pp. 53-63
EFFECT OF FLUCONAZOLE ON THE STEADY-STATE PHARMACOKINETICS OF DELAVIRDINE IN HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENTS
Authors: BORIN MT COX SR HERMAN BD CAREL BJ ANDERSON RD FREIMUTH WW
Citation: Mt. Borin et al., EFFECT OF FLUCONAZOLE ON THE STEADY-STATE PHARMACOKINETICS OF DELAVIRDINE IN HUMAN IMMUNODEFICIENCY VIRUS-POSITIVE PATIENTS, Antimicrobial agents and chemotherapy, 41(9), 1997, pp. 1892-1897
SINGLE-DOSE PHARMACOKINETICS OF DELAVIRDINE MESYLATE AND DIDANOSINE IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: MORSE GD FISCHL MA SHELTON MJ COX SR DRIVER M DEREMER M FREIMUTH WW
Citation: Gd. Morse et al., SINGLE-DOSE PHARMACOKINETICS OF DELAVIRDINE MESYLATE AND DIDANOSINE IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Antimicrobial agents and chemotherapy, 41(1), 1997, pp. 169-174
PHARMACOKINETIC STUDY OF THE INTERACTION BETWEEN RIFAMPIN AND DELAVIRDINE MESYLATE
Authors: BORIN MT CHAMBERS JH CAREL BJ GAGNON S FREIMUTH WW
Citation: Mt. Borin et al., PHARMACOKINETIC STUDY OF THE INTERACTION BETWEEN RIFAMPIN AND DELAVIRDINE MESYLATE, Clinical pharmacology and therapeutics, 61(5), 1997, pp. 544-553
RANDOMIZED, CONTROLLED PHASE I II TRIAL OF COMBINATION THERAPY WITH DELAVIRDINE (U-90152S) AND CONVENTIONAL NUCLEOSIDES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS/
Authors: DAVEY RT CHAITT DG REED GF FREIMUTH WW HERPIN BR METCALF JA EASTMAN PS FALLOON J KOVACS JA POLIS MA WALKER RE MASUR H BOYLE J COLEMAN S COX SR WATHEN L DAENZER CL LANE HC
Citation: Rt. Davey et al., RANDOMIZED, CONTROLLED PHASE I II TRIAL OF COMBINATION THERAPY WITH DELAVIRDINE (U-90152S) AND CONVENTIONAL NUCLEOSIDES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS/, Antimicrobial agents and chemotherapy, 40(7), 1996, pp. 1657-1664
DEVELOPMENT OF A RAPID CULTURE-BASED DELAVIRDINE SUSCEPTIBILITY ASSAY
Authors: CONWAY B ADAMS L MONTANER JSG OSHAUGHNESSY MV FOURIE S FREIMUTH WW
Citation: B. Conway et al., DEVELOPMENT OF A RAPID CULTURE-BASED DELAVIRDINE SUSCEPTIBILITY ASSAY, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 87-87
TRANSDOMINANT REV PROTEIN INHIBITS HIV REPLICATION WITHOUT AFFECTING T-CELL FUNCTION
Authors: MALIM MH FREIMUTH WW LIU J BOYLE TJ LYERLY HK CULLEN BR NABEL GJ
Citation: Mh. Malim et al., TRANSDOMINANT REV PROTEIN INHIBITS HIV REPLICATION WITHOUT AFFECTING T-CELL FUNCTION, Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 669-669
Risultati: 1-8 |